Tag: Vaccine Trials

BUT WHY?! Kenya Has Zero Cases But U.S Pharmaceutical Firm To Start Vaccine Trial + WHO Issues Monkeypox Advisory to Kenya

Tina Marie (Ms. Cat)

Video via Wongel Zelalem

Tonix will test its monkeypox vaccine in Kenya next year, and no eyes on accelerated path at FDA

The study of Tonix Pharmaceuticals’ live virus vaccine will occur at Kenya Medical Research Institute, or KEMRI, in the East African country, the partners said Thursday. While Kenya has no reported cases of the virus that leads to painful lesions, the country is close to the Democratic Republic of the Congo, which had 163 cases as of July 27, according to a CDC tracker.

…

Tonix has been working on monkeypox and smallpox for close to a decade, Lederman said. The company’s vaccine, dubbed TNX-801, is traced back to a research collaboration with the Department of Cell Biology at the University of Alberta.

Related:

Read More »

Long-Term Studies Of COVID-19 Vaccines Hurt By Placebo Recipients Getting Immunized

Tina Marie (Ms. Cat)

February 19, 2021:

Long-Term Studies Of COVID-19 Vaccines Hurt By Placebo Recipients Getting Immunized

Dr. Steven Goodman, a clinical trials specialist at Stanford University, says losing those control groups makes it more difficult to answer some important questions about COVID-19 vaccines.

“We don’t know how long protections lasts,” he says. “We don’t know efficacy against variants — for which we definitely need a good control arm — and we also don’t know if there are any differences in any of these parameters by age or race or infirmity.”

H/T: This is nuts, Moderna & Pfizer intentionally lost the clinical trial control group testing vaccine efficacy and safety